Jazz Pharmaceuticals PLC (JAZZ)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
15,446,424,000
EV to revenue ratio (TTM)
3.876
EV to ebitda
11.03
Financial Performance
Revenue (TTM)
4,601,286,000
Gross profit (TTM)
4,203,438,000
EBITDA
1,927,067,000
Profitability
Operating margin (TTM)
26.90%
Profit margin
20.40%
Return on assets (TTM)
6.86%
Return on equity (TTM)
22.10%
Per Share Metrics
Revenue per share (TTM)
74.6
EPS
14.6
Diluted EPS (TTM)
14.6
Book value
74.1
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
16.3
Trailing P/E
16.3
Forward P/E
10.89
PEG ratio
0.958
Price to sales ratio (TTM)
3.357
Price to book ratio (TTM)
3.254
Growth
Quarterly earnings growth (YoY)
15.50%
Quarterly revenue growth (YoY)
3.20%
Analyst Sentiment
Strong buy
7
Buy
11
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.36